MyAverix Finance
US · Healthcare
BioNTech SE (BNTX)
Biotechnology
BioNTech SE (BNTX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BNTX
BioNTech SE (BNTX) — FAQ
What is BNTX's P/E ratio?
The price-to-earnings (P/E) ratio for BioNTech SE (BNTX) is 25.00 (data as of 2026-05-23).
Does BioNTech SE pay a dividend?
Dividend yield is not available in the current snapshot for BioNTech SE (BNTX). Check the MyAverix Finance app for the latest dividend data.
What sector is BioNTech SE in?
BioNTech SE (BNTX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is BNTX listed on?
BNTX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.